|
medpundit |
||
 |
 |
|
Friday, March 02, 2007In 2003, the likelihood of positive results was 84 percent for studies with pharmaceutical involvement, versus 54 percent in studies without clear industry connections. Our analysis was small, consisting only of 140 trials, but similar associations have been documented before, in stroke trials, psychiatry trials, cardiovascular trials and several other areas of clinical research. The one previous study in oncology, looking at multiple myeloma, also found that pharmaceutical studies reported positive results in 74 percent of trials compared to 47 percent of non-industry-sponsored trials. posted by Sydney on 3/02/2007 07:53:00 PM 1 comments 1 Comments:
"certainly for-profit companies are under a lot of financial pressure. Maybe that causes them to make smarter or safer choices about what drugs to bring to trial."
By |
|
